A Pre-Procurement Project for improving cancer patients' benefit from Next Generation Sequencing (NGS) by developing an integrated and standardized NGS workflow and integrating information from cancer gene testing, pharmocogenetics testing and e-medication in proper presentation to medical doctors for supporting therapy decision making at bedside.

This 60 month H2020 project started in January 2020. 
The maximum Grant Agreement amount is €10.998.128,16